Rottinghaus Scott T. 4
4 · ENANTA PHARMACEUTICALS INC · Filed Aug 9, 2024
Insider Transaction Report
Form 4
Rottinghaus Scott T.
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2023-08-08$17.23/sh−1,467$25,276→ 25,533 total - Tax Payment
Common Stock
2024-08-08$12.73/sh−1,466$18,662→ 18,784 total
Footnotes (2)
- [F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.
- [F2]Such amount excludes securities acquired or disposed of subsequent to August 8, 2023.